Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol

Background:Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, and rheumatoid arthritis. Unlike other monoclonal antibodies such as infliximab and adalimumab, certolizumab does not contain an Fc fraction and hence does not induce complement activation. I...

Full description

Bibliographic Details
Main Authors: Mehmet Baysal, Elif Gülsüm Ümit, Fatih Sarıtaş, Nil Su Kodal, Ahmet Muzaffer Demir
Format: Article
Language:English
Published: Galenos Publishing House 2018-09-01
Series:Balkan Medical Journal
Subjects:
Certolizumab pegol
drug-induced
etiology
thrombotic microangiopathies
Online Access: http://balkanmedicaljournal.org/archives/archive-detail/article-preview/drug-nduced-thrombotic-microangiopathy-with-certol/19696

Internet

http://balkanmedicaljournal.org/archives/archive-detail/article-preview/drug-nduced-thrombotic-microangiopathy-with-certol/19696

Similar Items